Equities

QuantumPharm Inc

QuantumPharm Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)5.35
  • Today's Change0.05 / 0.94%
  • Shares traded6.19m
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jun 21 2024 09:08 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

QuantumPharm Inc is a China-based company principally engaged in the provision of drug discovery solutions and intelligent automation solutions. The Company operates its businesses through two segments. The Drug Discovery Solutions segment spans the full spectrum of the drug discovery and research process, providing modular standalone solutions to or collaborating with a diverse range of biotechnology and pharmaceutical companies and academic institutions for novel drug discovery endeavors. The Intelligent Automation Solutions segment includes solid-state research and development services and automated chemical synthesis services. Solid-state research and development services include computing services, wet laboratory services and comprehensive solutions.

  • Revenue in HKD (TTM)--
  • Net income in HKD--
  • Incorporated2017
  • Employees783.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Luye Pharma Group Ltd6.60bn572.50m10.68bn5.27k18.570.79318.011.620.1530.1531.773.580.2472.423.601,252,994.002.172.803.564.4568.4470.538.7810.391.213.100.393111.822.703.50-11.94-16.39-14.05--
SciClone Pharmaceuticals (Holdings) Ltd3.39bn1.21bn11.80bn1.05k10.113.228.663.481.851.855.225.810.75853.563.833,230,487.0026.9727.0933.3436.3274.6776.0635.5535.434.5033.700.0122.9814.7617.5031.1615.9625.65--
SSY Group Ltd6.46bn1.32bn13.36bn5.60k10.171.937.642.070.44270.44272.172.330.56373.003.011,154,109.0011.5910.5115.5814.0356.0158.7220.5718.621.6029.610.31738.560.45059.1017.447.663.9413.56
Zai Lab Ltd2.27bn-2.65bn13.63bn2.18k--2.25--6.00-2.73-2.732.346.110.26972.845.61---31.41-37.72-36.81-42.7262.8664.75-116.45-282.444.43--0.0596--24.03360.0324.51---3.45--
Simcere Pharmaceutical Group Ltd7.10bn768.31m14.42bn7.03k19.671.9113.112.030.28820.28822.722.970.61063.532.651,010,789.006.6010.178.9415.6075.4378.8210.8017.501.870.97420.165246.684.497.92-23.22-0.521323.93--
3SBio Inc8.40bn1.67bn14.80bn5.41k9.040.96517.171.760.67120.67123.446.290.34261.587.011,552,662.006.957.449.039.2984.9882.9120.3021.502.2622.720.2266--13.8411.26-19.133.948.78--
The United Laboratories Intl. Hldgs Ltd.14.77bn2.90bn15.84bn15.00k5.461.164.511.071.601.608.137.530.68713.366.15984,611.9013.517.8920.5212.6446.1144.1719.6612.731.74--0.105528.9921.2212.8470.8531.6624.1914.67
Grand Pharmaceutical Group Ltd10.53bn1.88bn16.93bn10.53k8.911.107.401.610.53560.53563.004.330.46922.9410.26999,581.408.4510.0911.6614.0161.9661.9718.0022.350.981922.960.183126.9410.1212.06-9.5921.415.6924.77
Genscript Biotech Corp6.55bn-745.13m18.05bn6.94k--1.66--2.75-0.3537-0.35373.115.120.2837.595.45944,491.30-11.97-18.34-18.27-26.1548.7854.68-42.30-64.914.65--0.1694--34.1729.4457.91--17.14--
QuantumPharm Inc-100.00bn-100.00bn18.23bn783.00------------------------------------------------30.80---33.08------
China Traditional Chinese Med Hldg CoLtd19.48bn1.38bn21.30bn17.30k15.420.93657.931.090.27430.27433.874.520.49851.472.161,125,783.003.844.605.857.0751.1857.077.709.771.489.830.177317.3526.699.9968.11-2.24-12.75--
WuXi XDC Cayman Inc2.28bn304.78m21.49bn1.18k64.403.6658.369.420.27860.27862.124.90------1,937,982.00--------26.35--13.35--4.03--0.0005--114.44--82.07------
RemeGen Co Ltd1.16bn-1.62bn22.93bn3.62k--3.81--19.82-3.01-3.012.156.870.18640.40054.31319,985.20-26.17-18.66-31.75-23.7576.4881.94-140.43-102.881.31-64.320.2682--40.16148.65-51.30--59.07--
HUTCHMED (China) Ltd6.54bn786.52m24.57bn1.99k31.454.3128.803.760.89670.89677.616.540.72587.197.693,289,736.008.76-14.3513.36-20.4354.1236.5712.06-31.442.60--0.1038--96.5231.38127.93--38.65--
Data as of Jun 21 2024. Currency figures normalised to QuantumPharm Inc's reporting currency: Hong Kong Dollar HKD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.